An ounce of cancer prevention is worth a moment of your attention
11/24/2015
What if you could visit the doctor for a blood test that predicted your personal cancer risk - then got a simple prescription that reduced that risk?
Pembrolizumab in advanced melanoma: Added benefit for certain patients
11/24/2015
Fewer side effects in certain pretreated patients; treatment-naive patients without tumor mutation survive longer.
Although based on early data, study findings suggest an association between the Affordable Care Act Dependent Coverage Expansion provision and cervical cancer stage at diagnosis and receipt of...
New ASTRO template helps radiation oncologists guide cancer survivors through ongoing care
11/24/2015
A new template published by the American Society for Radiation Oncology (ASTRO) standardizes and streamlines the creation of patient-focused plans for long-term cancer survivor care following...
Causal link between aneuploidy and cancer
11/24/2015
Publication in Nature Cell Biology: researchers at the Université libre de Bruxelles - ULB Cancer Research Center, U-CRC - show the causal link between aneuploidy and cancer.
Exploring the causes of cancer
11/24/2015
Cells communicate with other cells in our bodies by sending and receiving signals. Cancer can occur when these signals are "dysregulated" and abnormal cells grow out of control.
Although based on early data, study findings suggest an association between the Affordable Care Act Dependent Coverage Expansion provision and cervical cancer stage at diagnosis and receipt of...
Genmab A/S has announced that the Phase III study of single agent ofatumumab compared to single agent rituximab in patients with follicular non-Hodgkin's lymphoma (NHL) that has relapsed at least 6...
A new brachytherapy technique using a shield that rotates in a corkscrew pattern inside a tube-shaped intrauterine applicator could improve cervical cancer treatments, boosting the radiation dose...
FDA approves Opdivo to treat advanced form of kidney cancer
11/24/2015
The U.S. Food and Drug Administration has approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of...